OXTR and obesity due to melanocortin 4 receptor deficiency: Considering the other identified genes, targeting OXTR, which encodes a protein that mediates anabolic skeletal recovery [31, 32], has been suggested as a possible therapeutic target for osteoporosis and obesity.